Test mBank mfor mRuppel’s mManual mof mPulmonary
mFunction mTesting m12th mEdition, mBy mMottram
Chapter m1 m- m13 mUpdated m
,Chapter m1: mIndications mfor mPulmonary mFunction mTesting
mTest mBank
MULTIPLE mCHOICE
1. Who mfirst mpopularized mspirometry mfor mthe mevaluation mof mpulmonary
mfunction?
a. August mand mMarie mKrogh
b. Alvan mBarach
c. John mSeveringhaus
d. John mHutchinson
ANS: mD
Hutchinson mpopularized mthe mconcept mof musing mVC mto massess mlung mfunction,
mand mthe mnames mhe mgave mto mseveral mother mlung mcompartments mare mstill
mused mtoday.
DIF: 1 REF: p. m2 OBJ: None m MSC: mNBRC: mNone
2. Which mof mthe mfollowing mare mindications mfor mperforming mspirometry?
1. Assess mthe mrisk mof mlung mresection.
2. Determine mthe mresponse mto mbronchodilator mtherapy.
3. Assess mthe mseverity mof mrestrictive mlung mdisease.
4. Quantify mthe mextent mof mCOPD.
a. 1 m and m 4
b. 2 m and m 3
c. 1 m, m2, mand m 4
d. 2 m, m3, mand m 4
ANS: mC
Spirometry mcannot massess mseverity mof mrestriction; mfor mthat myou mneed mto
mmeasure mlung mvolumes m( msee mBox m1-2, mChapter m 1).
DIF: 1 REF: p. m7 OBJ: EL-2 MSC: mNBRC: mNone
,3. The mmain mindication mfor mthe mmeasurement mof mlung mvolumes mis mto mdo
mwhich mof mthe mfollowing?
a. Diagnose mor massess mthe mseverity mof mrestriction.
b. Evaluate mthe mseverity mof mpulmonary mhypertension.
c. Determine mthe mlevel mof mcardiopulmonary mfitness.
d. Assess mthe mrisk mof mabdominal msurgical mprocedures.
ANS: mA
The mmost mcommon mreason mfor mmeasuring mlung mvolumes mis mto midentify
mrestrictive mlung mdisease. mDIF: 1 REF: p. m35 OBJ: EL-2 MSC:
mNBRC: mNone
4. DLCO mmeasurements mmay mbe mindicated mto mevaluate mpulmonary
minvolvement min mwhich mof mthe mfollowing msystemic mdiseases?
a. Asthma
b. Sarcoidosis
c. Exertional mhypoxemia
, Stuvia.com m- mThe mMarketplace mto mBuy mand mSell myour
mStudy mMaterial
d. Guillain-Barré msyndrome
ANS: mB
Sarcoidosis mis mthe monly msystemic mdisease mlisted mthat maffects
mgas mexchange. mDIF: m1 mREF: mp. m9 m| mp. m19 m| mp. m21
m| mp. m35 mOBJ: mEL-2 mMSC: mNBRC: mNone
5. Blood mgas manalysis mis mused mwith mpatients mwith mCOPD
mto mdo mwhich mof mthe mfollowing?
a. Monitor mairway mresponsiveness.
b. Determine mlevel mof mcardiopulmonary mfitness.
c. Detect mpulmonary mhypertension.
d. Assess mneed mfor msupplementary mO2.
ANS: mD
Blood mgas manalysis mis mmost mcommonly mused mto mdetermine mthe mneed mfor
msupplemental moxygen mand mto mmanage mpatients mwho mrequire mventilatory
msupport.
DIF: 2 REF: p. m15 OBJ: EL-1
mMSC: mNBRC: mCPFT m2A-2
6. Which mof mthe mfollowing mcause memphysema?
1. 1- mAntitrypsin mdeficiency
2. Exposure mto menvironmental mpollutants
3. Radiation mtherapy
4. Cigarette msmoking
a. 1 m and m 2
b. 3 m and m 4
c. 1 m, m2, mand m 4
d. 2 m, m3, mand m 4
ANS: mC
Emphysema mis mcaused mprimarily mby mcigarette msmoking. mSome memphysema mis
mcaused mby mthe mabsence mof ma mprotective menzyme. mChronic mexposure mto
menvironmental mpollutants mcan malso mcontribute mto mthe mdevelopment mof
memphysema.
DIF: 1 REF: p. m11 OBJ: EL-3 m| mAL-2 MSC: mNBRC: mNone
7. An madult mpatient mcomplains mof mchest mtightness mand mcough mwhenever mhe
mjogs min mcold mweather. mThese msymptoms mare mconsistent mwith mwhich mof
mthe mfollowing?
a. Cystic mfibrosis
b. Asthma
c. Pulmonary mhypertension
|
mFunction mTesting m12th mEdition, mBy mMottram
Chapter m1 m- m13 mUpdated m
,Chapter m1: mIndications mfor mPulmonary mFunction mTesting
mTest mBank
MULTIPLE mCHOICE
1. Who mfirst mpopularized mspirometry mfor mthe mevaluation mof mpulmonary
mfunction?
a. August mand mMarie mKrogh
b. Alvan mBarach
c. John mSeveringhaus
d. John mHutchinson
ANS: mD
Hutchinson mpopularized mthe mconcept mof musing mVC mto massess mlung mfunction,
mand mthe mnames mhe mgave mto mseveral mother mlung mcompartments mare mstill
mused mtoday.
DIF: 1 REF: p. m2 OBJ: None m MSC: mNBRC: mNone
2. Which mof mthe mfollowing mare mindications mfor mperforming mspirometry?
1. Assess mthe mrisk mof mlung mresection.
2. Determine mthe mresponse mto mbronchodilator mtherapy.
3. Assess mthe mseverity mof mrestrictive mlung mdisease.
4. Quantify mthe mextent mof mCOPD.
a. 1 m and m 4
b. 2 m and m 3
c. 1 m, m2, mand m 4
d. 2 m, m3, mand m 4
ANS: mC
Spirometry mcannot massess mseverity mof mrestriction; mfor mthat myou mneed mto
mmeasure mlung mvolumes m( msee mBox m1-2, mChapter m 1).
DIF: 1 REF: p. m7 OBJ: EL-2 MSC: mNBRC: mNone
,3. The mmain mindication mfor mthe mmeasurement mof mlung mvolumes mis mto mdo
mwhich mof mthe mfollowing?
a. Diagnose mor massess mthe mseverity mof mrestriction.
b. Evaluate mthe mseverity mof mpulmonary mhypertension.
c. Determine mthe mlevel mof mcardiopulmonary mfitness.
d. Assess mthe mrisk mof mabdominal msurgical mprocedures.
ANS: mA
The mmost mcommon mreason mfor mmeasuring mlung mvolumes mis mto midentify
mrestrictive mlung mdisease. mDIF: 1 REF: p. m35 OBJ: EL-2 MSC:
mNBRC: mNone
4. DLCO mmeasurements mmay mbe mindicated mto mevaluate mpulmonary
minvolvement min mwhich mof mthe mfollowing msystemic mdiseases?
a. Asthma
b. Sarcoidosis
c. Exertional mhypoxemia
, Stuvia.com m- mThe mMarketplace mto mBuy mand mSell myour
mStudy mMaterial
d. Guillain-Barré msyndrome
ANS: mB
Sarcoidosis mis mthe monly msystemic mdisease mlisted mthat maffects
mgas mexchange. mDIF: m1 mREF: mp. m9 m| mp. m19 m| mp. m21
m| mp. m35 mOBJ: mEL-2 mMSC: mNBRC: mNone
5. Blood mgas manalysis mis mused mwith mpatients mwith mCOPD
mto mdo mwhich mof mthe mfollowing?
a. Monitor mairway mresponsiveness.
b. Determine mlevel mof mcardiopulmonary mfitness.
c. Detect mpulmonary mhypertension.
d. Assess mneed mfor msupplementary mO2.
ANS: mD
Blood mgas manalysis mis mmost mcommonly mused mto mdetermine mthe mneed mfor
msupplemental moxygen mand mto mmanage mpatients mwho mrequire mventilatory
msupport.
DIF: 2 REF: p. m15 OBJ: EL-1
mMSC: mNBRC: mCPFT m2A-2
6. Which mof mthe mfollowing mcause memphysema?
1. 1- mAntitrypsin mdeficiency
2. Exposure mto menvironmental mpollutants
3. Radiation mtherapy
4. Cigarette msmoking
a. 1 m and m 2
b. 3 m and m 4
c. 1 m, m2, mand m 4
d. 2 m, m3, mand m 4
ANS: mC
Emphysema mis mcaused mprimarily mby mcigarette msmoking. mSome memphysema mis
mcaused mby mthe mabsence mof ma mprotective menzyme. mChronic mexposure mto
menvironmental mpollutants mcan malso mcontribute mto mthe mdevelopment mof
memphysema.
DIF: 1 REF: p. m11 OBJ: EL-3 m| mAL-2 MSC: mNBRC: mNone
7. An madult mpatient mcomplains mof mchest mtightness mand mcough mwhenever mhe
mjogs min mcold mweather. mThese msymptoms mare mconsistent mwith mwhich mof
mthe mfollowing?
a. Cystic mfibrosis
b. Asthma
c. Pulmonary mhypertension
|